From humble to global: China’s biotechs navigate the demands of international trials
Driven by regulatory reforms that are accelerating drug approvals and a wave of licensing deals with Western partners, Chinese life…
All articles by Catherine Longworth
Catherine Longworth
@MedtechCate
Catherine Longworth is the Editor for Medical Device Network, covering developments across the medical technology and health tech industry. An experienced writer, Catherine has covered the industry since 2016 and has a background in biomedical science and journalism. Her previous experience includes reporting for Medtech Insight (Citeline, formerly Informa Pharma Intelligence) and Bioworld (Clarivate).
-
-
Navigating regulatory change in APAC: Insights from the upcoming BioSecure Act Webinar
The regulatory landscape across the Asia-Pacific (APAC) region is evolving rapidly, and pharmaceutical companies must adapt to maintain compliance, mitigate…
-
China’s clinical trial ecosystem takes centre stage in Suzhou this September
China’s rapid emergence as a global clinical trials powerhouse will be in sharp focus this September as leading voices from…
-
Cannabis on the NHS? Research is the gateway to wider access
“Families are fundraising to keep their children alive.” That was the stark message delivered at Cannabis Europa in London, where…
-
AI should unlock clinical trial data, say experts
Artificial intelligence (AI) has the potential to uncover valuable insights hidden in protocols and clinical study reports across the pharmaceutical…
-
Diversity commitment persists in clinical trials amidst policy shifts
Despite major policy rollbacks on diversity, equity, and inclusion (DEI) at the US federal level, clinical research leaders have made…
-
Examining shifts in clinical trial outsourcing
As clinical trials grow increasingly complex and globalised, industry leaders continue to reassess how outsourcing models can drive efficiency and…
-
Harnessing LLMs in clinical trial management
The use of large language models (LLMs) such as ChatGPT will be key in enhancing clinical trial management according to…
-
Genolier Health Innovation Hub opens in Switzerland
A new health innovation hub has launched in Switzerland with the aim of accelerating late stage medical research into clinical…
-
“Leave politics out of healthcare” – controversy swirls around BIOSECURE Act
Members of the biotech industry have voiced concerns about the impact of the BIOSECURE Act, after the bill passed through…